asal High-Frequency Oscillation to Improve Respiratory Stability of Preterm Infants: A Randomized Crossover Study
Not Applicable
Completed
- Conditions
- Desaturations and bradycardias related to apnoea of prematurityReproductive Health and Childbirth - Childbirth and postnatal careRespiratory - Other respiratory disorders / diseasesCardiovascular - Other cardiovascular diseases
- Registration Number
- ACTRN12616001516471
- Lead Sponsor
- The Royal Women's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Gestational age at birth: < 30 weeks
- Postmenstrual age: greater than or equal to 26 and < 34 completed weeks of gestation
- Postnatal age: > 7 days
- Respiratory support: Receiving nasal CPAP and extubated for greater than or equal to 24 hours.
Exclusion Criteria
- Participation in another study that prohibits inclusion
- Nasal trauma and Pressure Injury score greater than or equal to 2 (stage 2: partial thickness skin loss involving epidermis, dermis or both) before study entry
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference in the total number of desaturations and bradycardias between CPAP and nHFO treatment during 120-minute recording periods for each therapy.[120 minutes of nHFO (intervention period) compared to 120 minutes of CPAP (baseline period).<br><br>An oximetry sensor (LNOP Neo sensor; Masimo, Irvine, California, USA) will be placed around the infant’s wrist or foot and connected to the pulse oximeter (Radical7 V5; Masimo, 2 second averaging mode). Continuous data will be recorded using a neonatal respiratory monitor (NewLifeBox Neo-RSD, Advanced Life Diagnostics UG, Weener, Germany).]
- Secondary Outcome Measures
Name Time Method